Live-seq brings longitudinal, non-destructive cell sequencing to every lab, revealing new insights into cellular behavior ...
Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) ...
2d
Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Investor's Business Daily on MSN
IBD 50's Tempus AI Pulls Back From Record High After Another FDA Clearance
Tempus AITEM stock surged to a record high Monday after the Food and Drug Administration cleared its new device to help ...
Tempus AI Inc. shares rose after it said it received 510 (k) clearance from the Food and Drug Administration for its RNA-based in vitro diagnostic device. Its stock recently rose 5.2% to $92.85 in ...
The table shows the representative samples and their associated read counts. AutoNormalization effectively normalized the ...
Background Molecular genetic diagnoses are critical to prevention and treatment of inherited polyposis and colorectal cancer.
This year marks the 25th anniversary of the publication of the Human Genome Project, a monumental scientific achievement that has transformed healthcare and laid the foundation for modern genomics.
Scientists at Cold Spring Harbor Laboratory have cracked open the secrets of plant stem cells, mapping key genetic regulators in maize and Arabidopsis. By using single-cell RNA sequencing, they ...
The "United States Next Generation Sequencing Market - Applications & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering.United States Next Generation Sequencing Market is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback